These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8120668)

  • 1. Vitamin E did not prevent platelet activation, but prevented increase of lipid peroxides and renal dysfunction in DOCA-salt hypertensive rats.
    Umegaki K; Ichikawa T
    J Nutr Sci Vitaminol (Tokyo); 1993 Oct; 39(5):437-49. PubMed ID: 8120668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin E administration on platelet function and serum lipid peroxides in DOCA-salt hypertensive rats.
    Umegaki K; Saegusa H; Kurokawa M; Ichikawa T
    Thromb Haemost; 1991 Apr; 65(4):411-4. PubMed ID: 2057924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgo biloba extract attenuates the development of hypertension in deoxycorticosterone acetate-salt hypertensive rats.
    Umegaki K; Shinozuka K; Watarai K; Takenaka H; Yoshimura M; Daohua P; Esashi T
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):277-82. PubMed ID: 10779125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.
    Jin L; Beswick RA; Yamamoto T; Palmer T; Taylor TA; Pollock JS; Pollock DM; Brands MW; Webb RC
    J Physiol Pharmacol; 2006 Sep; 57(3):343-57. PubMed ID: 17033089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats.
    Lan CZ; Ding L; Su YL; Guo K; Wang L; Kan HW; Ou YR; Gao S
    Food Funct; 2015 Jul; 6(7):2179-2186. PubMed ID: 26011796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum and renal vitamin E levels in deoxycorticosterone acetate-salt hypertensive rats.
    Seifi B; Kadkhodaee M; Zahmatkesh M; Golab F; Bakhshi E
    Transplant Proc; 2009 Sep; 41(7):2910-1. PubMed ID: 19765471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin E therapy on serum uric acid in DOCA-salt-treated rats.
    Seifi B; Kadkhodaee M; Zahmatkesh M
    Acta Physiol Hung; 2011 Jun; 98(2):214-20. PubMed ID: 21616780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
    Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
    Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats.
    Kh R; Khullar M; Kashyap M; Pandhi P; Uppal R
    J Hypertens; 2000 Jul; 18(7):919-26. PubMed ID: 10930190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage.
    Seifi B; Kadkhodaee M; Karimian SM; Zahmatkesh M; Xu J; Soleimani M
    Clin Exp Hypertens; 2010 Jan; 32(2):90-7. PubMed ID: 20374182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in platelet function due to hypertension: comparison of experimental hypertension with spontaneous hypertension in rats.
    Umegaki K; Nakamura K; Ikeda M; Inoue Y; Tomita T
    J Hypertens; 1989 Jan; 7(1):13-9. PubMed ID: 2708809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
    Oyekan AO; McAward K; Conetta J; Rosenfeld L; McGiff JC
    Am J Physiol; 1999 Mar; 276(3):R766-75. PubMed ID: 10070137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary calcium on the development of hypertension and hypertensive vascular lesions in DOCA-salt and two-kidney, one clip hypertensive rats.
    Liu DT; Birchall I; Hewitson T; Kincaid-Smith P; Whitworth JA
    J Hypertens; 1994 Feb; 12(2):145-53. PubMed ID: 8021465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.